FST-344

$130.00

Discover FST-344 (Follistatin-344), a research protein studied for myostatin inhibition, muscle biology, and TGF-β signaling. Research use only.

Category:
Description

SEO Product Description: FST-344 (Research Use Only)

FST-344 (Follistatin-344) is a research-grade recombinant protein studied for its interaction with the myostatin (GDF-8) and activin signaling pathways. As a naturally occurring follistatin isoform, FST-344 has attracted significant interest in laboratory research involving skeletal muscle biology, tissue regeneration, and TGF-β superfamily signaling. Current evidence is primarily derived from preclinical studies and gene therapy research; FST-344 is not an approved medication for human use. (ScienceDirect)

Key Research Features

  • Research-grade Follistatin-344 (FST-344).
  • Investigated for interactions with myostatin (GDF-8) and activin.
  • Widely studied in muscle biology and regenerative medicine research.
  • Intended for laboratory research only.
  • Manufactured for analytical and scientific investigation—not for therapeutic or diagnostic use.

Research Applications

Researchers have explored FST-344 in studies related to:

  • Myostatin inhibition mechanisms
  • Skeletal muscle development
  • Muscle regeneration and repair
  • TGF-β signaling pathways
  • Gene therapy and neuromuscular disease research
  • Cell signaling and protein interaction studies (ScienceDirect)

Quality & Handling

  • Produced under research-grade quality standards.
  • Suitable for qualified laboratory professionals.
  • Store and handle according to the manufacturer’s recommendations to maintain stability.

Important Notice

FST-344 is intended exclusively for research purposes. It is not approved for human or veterinary use, and its safety and effectiveness for clinical use have not been established.



Additional information
Dosage1mg*10vials
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “FST-344”

Your email address will not be published. Required fields are marked *